Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis

被引:5
作者
Jafarinejad-Farsangi, Saeideh [1 ]
Moazzam-Jazi, Maryam [2 ]
Ghale-noie, Zari Naderi [3 ]
Askari, Nahid [4 ]
Karam, Zahra Miri [5 ]
Mollazadeh, Samaneh [6 ]
Hadizadeh, Morteza [7 ]
机构
[1] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran
[3] Mashhad Univ Med Sci, Fac Med, Dept Med Genet, Mashhad, Razavi Khorasan, Iran
[4] Grad Univ Adv Technol, Dept Biotechnol, Inst Sci & High Technol & Environm Sci, Kerman, Iran
[5] Kerman Univ Med Sci, Student Res Ctr, Kerman, Iran
[6] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran
[7] Kerman Univ Med Sci, Student Res Ctr, Kerman, Iran
关键词
Breast cancer; Breast cancer subtypes; Microarray; Gene expression meta-analysis; INHBA EXPRESSION; IDENTIFICATION; MICROARRAY; PACKAGE;
D O I
10.1016/j.gene.2022.146328
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Molecular-based studies have revealed heterogeneity in Breast cancer BC while also improving classification and treatment. However, efforts are underway to distinguish between distinct subtypes of breast cancer. In this study, the results of several microarray studies were combined to identify genes and pathways specific to each BC subtype. Methods: Meta-analysis of multiple gene expression profile datasets was screened to find differentially expressed genes (DEGs) across subtypes of BC and normal breast tissue samples. Protein-protein interaction network and gene set enrichment analysis were used to identify critical genes and pathways associated with BC subtypes. The differentially expressed genes from meta-analysis was validated using an independent comprehensive breast cancer RNA-sequencing dataset obtained from the Cancer Genome Atlas (TCGA). Results: We identified 110 DEGs (13 DEGs in all and 97 DEGs in each subtype) across subtypes of BC. All subtypes had a small set of shared DEGs enriched in the Chemokine receptor bind chemokine pathway. Luminal A specific were enriched in the translational elongation process in mitochondria, and the enhanced process in luminal B subtypes was interferon-alpha/beta signaling. Cell cycle and mitotic DEGs were enriched in the basal-like group. All subtype-specific DEG genes (100%) were successfully validated for Luminal A, Luminal B, ERBB2, and Normal-like. However, the validation percentage for Basal-like group was 77.8%. Conclusion: Integrating researches such as a meta-analysis of gene expression might be more effective in uncovering subtype-specific DEGs and pathways than a single-study analysis. It would be more beneficial to increase the number of studies that use matched BC subtypes along with GEO profiling approaches to reach a better result regarding DEGs and reduce probable biases. However, achieving 77.8% overlap in basal-specific genes and complete concordance in specific genes related to other subtypes can implicate the strength of our analysis for discovering the subtype-specific genes.
引用
收藏
页数:9
相关论文
共 42 条
  • [1] Aziz SW, 2013, BREAST CANC METASTAS, P47, DOI [10.1007/978-1-4614-5647-6_4, DOI 10.1007/978-1-4614-5647-6_4]
  • [2] Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
    Badve, Sunil
    Dabbs, David J.
    Schnitt, Stuart J.
    Baehner, Frederick L.
    Decker, Thomas
    Eusebi, Vincenzo
    Fox, Stephen B.
    Ichihara, Shu
    Jacquemier, Jocelyne
    Lakhani, Sunil R.
    Palacios, Jose
    Rakha, Emad A.
    Richardson, Andrea L.
    Schmitt, Fernando C.
    Tan, Puay-Hoon
    Tse, Gary M.
    Weigelt, Britta
    Ellis, Ian O.
    Reis-Filho, Jorge S.
    [J]. MODERN PATHOLOGY, 2011, 24 (02) : 157 - 167
  • [3] Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
    Callari, Maurizio
    Musella, Valeria
    Di Buduo, Eleonora
    Sensi, Marialuisa
    Miodini, Patrizia
    Dugo, Matteo
    Orlandi, Rosaria
    Agresti, Roberto
    Paolini, Biagio
    Carcangiu, Maria Luisa
    Cappelletti, Vera
    Daidone, Maria Grazia
    [J]. MOLECULAR ONCOLOGY, 2014, 8 (07) : 1278 - 1289
  • [4] Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis
    Cao, Wenning
    Jiang, Yike
    Ji, Xiang
    Guan, Xuejiao
    Lin, Qianyu
    Ma, Lan
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [5] Castillo D., BMC BIOINFORMATICS, V18, P1
  • [6] Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis
    Deng, Jun-Li
    Xu, Yun-hua
    Wang, Guo
    [J]. FRONTIERS IN GENETICS, 2019, 10
  • [7] Evolution of Genetic Techniques: Past, Present, and Beyond
    Durmaz, Asude Alpman
    Karaca, Emin
    Demkow, Urszula
    Toruner, Gokce
    Schoumans, Jacqueline
    Cogulu, Ozgur
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [8] Gonzales Mildred C, 2018, Oncotarget, V9, P29019, DOI 10.18632/oncotarget.25520
  • [9] Activating mutations in ERBB2 and their diagnostics and treatment
    Herter-Sprie, Grit S.
    Greulich, Heidi
    Wong, Kwok-Kin
    [J]. FRONTIERS IN ONCOLOGY, 2013, 3
  • [10] Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases
    Huang, Guomin
    Li, Hongyan
    Zhang, Hong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 19